Arphra/Issuer/IONS

IONS

Ionis Pharmaceuticals, Inc.

HealthcareBiotechnologyUSUSD

$75.38

LiveJun 01, 2026

AI Brief

Market cap

$12.46B

52w range

33.95 – 86.74

P / E

—

EPS

—

Volume

1.47M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Ionis Pharmaceuticals, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for IONS.

Peers

No peer list available for IONS.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-1.46%	-1.57%	+0.13%	-8.03%	-7.29%	-4.71%	+120.99%	+80.55%	+111.27%	+217.39%	+653.80%

Aftermarket

Live

Jun 02, 08:59 AM

Last trade

$76.30

1 sh

Bid

$75.00

1 sh

Ask

$77.60

82 sh

Spread

$2.600

Sector & industry today

Live

Sectors

Technology
+3.30%
Basic Materials
+0.98%
Energy
+0.83%
Consumer Cyclical
+0.49%
Industrials
+0.25%
Communication Services
+0.13%
Healthcare
-0.65%
Financial Services
-0.80%
Consumer Defensive
-0.84%
Utilities
-1.15%
Real Estate
-1.32%

Top industries (issuer's industry highlighted)

Biotechnology
-2.72%
Computer Hardware
+8.35%
Software - Infrastructure
+7.61%
Consulting Services
+5.28%
Coal
+5.20%
Manufacturing - Metal Fabrication
+4.24%
Staffing & Employment Services
+4.08%
Gambling, Resorts & Casinos
+3.71%
Broadcasting
+3.70%
Integrated Freight & Logistics
+3.68%
REIT - Healthcare Facilities
-3.49%
Software - Application
+3.44%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $107.27 (+42.31%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin